International ACTEMRA Rheumatoid Arthritis Study Highlighted In The Lancet
Patients with rheumatoid arthritis treated with Roche’s ACTEMRA(TM) (tocilizumab) experienced significant and rapid reduction in the signs and symptoms of their disease, according to a study published in this week’s issue of The Lancet.
More: continued here
Filed under: Arthritis on April 2nd, 2008